KEUTZER TIMOTHY (Chief Development Officer) sold 5.5% of their position (30.97K shares) of SPERO THERAPEUTICS, INC. on the open market
Open‑market sale worth $42.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/5/2024ACC: 0000950170-24-011501
Officer· Chief Development Officer
Since Jan 2020
+208.76K
Net shares
Net buyer
$42.1K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
239.73K acquired · 30.97K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+239.73K
Price / share
—
Trade value
—
% of position
73.7%
2/1/2024
325.29K→565.02K
Common Stock
Direct
Shares
−30.97K
Price / share
$1.36
Trade value
$42.12K
% of position
5.5%
2/2/2024
565.02K→534.05K
Total
Net shares
+208.76K
Net value
-$42.12K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/1/2024 | A · Award | +239.73K | — | — | 73.7% | 325.29K | 565.02K |
| Common Stock Direct | 2/2/2024 | S · Sale | −30.97K | $1.36 | $42.12K | 5.5% | 565.02K | 534.05K |
| Total | +208.76K | -$42.12K | ||||||
Derivative Transactions0
No derivative transactions reported